Short Interest in Zentek Ltd. (NASDAQ:ZTEK) Rises By 35.5%

Key Points

• Zentek Ltd. experienced a **35.5% increase** in short interest in July, with a total of **94,700 shares** shorted, resulting in a short-interest ratio of **2.5 days** based on an average trading volume of **38,000 shares**.
• An institutional investor, Anson Funds Management LP, purchased **154,933 shares** of Zentek, amounting to approximately **$145,000**, which represents around **0.15%** of the company's total shares owned.

Zentek Ltd. (NASDAQ:ZTEK - Get Free Report) saw a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 94,700 shares, anincreaseof35.5% from the July 15th total of 69,900 shares. Based on an average daily volume of 38,000 shares, the short-interest ratio is presently 2.5 days. Currently,0.1% of the company's stock are short sold. Currently,0.1% of the company's stock are short sold. Based on an average daily volume of 38,000 shares, the short-interest ratio is presently 2.5 days.

Zentek Stock Down 2.3%

ZTEK stock traded down $0.0161 during mid-day trading on Friday, hitting $0.6840. The stock had a trading volume of 19,564 shares, compared to its average volume of 31,649. The company has a current ratio of 1.62, a quick ratio of 1.30 and a debt-to-equity ratio of 0.12. Zentek has a 1-year low of $0.4999 and a 1-year high of $1.8411. The company has a fifty day moving average of $0.99 and a 200 day moving average of $1.16. The stock has a market capitalization of $71.62 million, a price-to-earnings ratio of -13.68 and a beta of 0.47.

Zentek (NASDAQ:ZTEK - Get Free Report) last issued its earnings results on Thursday, August 14th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.04 million during the quarter. Zentek had a negative return on equity of 55.41% and a negative net margin of 981.17%.

Hedge Funds Weigh In On Zentek

An institutional investor recently bought a new position in Zentek stock. Two Sigma Securities LLC purchased a new stake in shares of Zentek Ltd. (NASDAQ:ZTEK - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 33,128 shares of the company's stock, valued at approximately $31,000. Institutional investors and hedge funds own 0.77% of the company's stock.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.